| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |